Skip to main content
SpringerLink
Log in

Matrix metalloproteinases in serum and the follicular fluid of women treated by in vitro fertilization

  • ASSISTED REPRODUCTION TECHNOLOGIES
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To assess levels of matrix metalloproteinases 2 and 9 (MMP-2 and MMP-9) in follicular fluids and sera of female patients undergoing in vitro fertilization (IVF) treatment, and discover the role of MMPs in IVF outcome prediction.

Methods

Sera and follicular fluids were obtained from 58 female patients treated for infertility by IVF. Twenty-nine of them became pregnant after the embryo-transfer; another 29 were not successful in IVF and did not conceive. Forty female non-pregnant blood donors and 38 healthy pregnant patients in the first trimester after the physiological conception were examined as control groups. MMP-2 and MMP-9 were quantitively assessed using enzyme-linked immunosorbent assay.

Results

IVF females successfully conceiving after the IVF have shown the highest MMP-9 concentrations in sera (833.5 {686.0;958.7} ng/mL) and follicular fluids (9.6 {6.0; 17.0} ng/mL) compared to all other examined cohorts. Different behavior of MMP-2 and MMP-9 during the artificial ovulation was confirmed, because only MMP-9 has shown a vast difference between serum and follicular concentrations.

Conclusions

MMP-9 could be a good predictor of the successful IVF outcome (pregnancy), which was proven for serum as well as follicular MMP-9 levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Baka S, Zourla K, Kouskouni E, Makrakis E, Demeridou S, Tzanakaki D, Hassiakos D, Creatsas G. Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation. In Vivo. 2010;24(3):293–6.

    PubMed  CAS  Google Scholar 

  2. Baka S, Zourla K, Malamitsi-Puchner A, Makrakis E, Kaparos G, Demeridou S, Moustakarias T, Tzanakaki D, Hassiakos D, Kouskouni E. Intrafollicular levels of matrix metalloproteinases-2 and -9 in patients with polycystic ovaries are not associated with pregnancy rate during IVF cycle. In Vivo. 2009;23(1):89–92.

    PubMed  CAS  Google Scholar 

  3. Bischof P, Meisser A, Campana A. Control of MMP-9 expression at the maternal-fetal interface. J Reprod Immunol. 2002;55(1–2):3–10.

    Article  PubMed  CAS  Google Scholar 

  4. Curry Jr TE, Song L, Wheeler SE. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat. Biol Reprod. 2001;65(3):855–65.

    Article  PubMed  CAS  Google Scholar 

  5. Curry Jr TE, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev. 2003;24(4):428–65.

    Article  PubMed  CAS  Google Scholar 

  6. D’Ascenzo S, Giusti I, Millimaggi D, Marci R, Tatone C, Colonna RC, Moscarini M, Pavan A, et al. Intrafollicular expression of matrix metalloproteinases and their inhibitors in normally ovulating women compared with patients undergoing in vitro fertilization treatment. Eur J Endocrinol. 2004;151(1):87–91.

    Article  PubMed  Google Scholar 

  7. Dubois B, Arnold B, Opdenakker G. Gelatinase B deficiency impairs reproduction. J Clin Invest. 2000;106(5):627–8.

    Article  PubMed  CAS  Google Scholar 

  8. Eng J. ROC analysis: web-based calculator for ROC curves. Baltimore: Johns Hopkins University, 2006. Available from: http://www.jrocfit.org.

  9. Fu J, Wang XJ, Wang YW, Sun J, Gemzell-Danielsson K, Sun XX. The influence of early cleavage on embryo developmental potential and IVF/ICSI outcome. J Assist Reprod Genet. 2009;26(8):437–41.

    Article  PubMed  CAS  Google Scholar 

  10. Gomes VA, Vieira CS, Jacob-Ferreira AL, Belo VA, Soares GM, Fernandes JB, Ferriani RA, Tanus-Santos JE. Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome. Mol Cell Biochem. 2011;353(1–2):251–7.

    Article  PubMed  CAS  Google Scholar 

  11. Gottsch ML, Van Kirk EA, Murdoch WJ. Role of matrix metalloproteinase 2 in the ovulatory folliculo-luteal transition of ewes. Reproduction. 2002;124:347–52.

    Article  PubMed  CAS  Google Scholar 

  12. Isaka K, Nishi H, Nakai H, Nakada T, Feng Li Y, Ebihara Y, Takayama M. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma. Cancer. 2003;97(1):79–89.

    Article  PubMed  CAS  Google Scholar 

  13. Jovanović M, Stefanoska I, Radojcić L, Vićovac L. Interleukin-8 (CXCL8) stimulants trophoblast cell migration and invasion by increasing levels of matrix metalloporteinase (MMP)2 and (MMP)9 and integrin alpha5 and beta1. Reproduction. 2010;139(4):789–98.

    Article  PubMed  Google Scholar 

  14. Koucký M, Germanová A, Kalousová M, Hill M, Cindrová-Davies T, Pařízek A, Svarcová J, Zima T. Low maternal serum matrix metalloproteinases (MMP)-2 concentrations are associated with preterm labor and fetal inflammatory response. J Perinat Med. 2010;38(6):589–96.

    Article  PubMed  Google Scholar 

  15. Lee DM, Lee TK, Song HB, Kim CH. The expression of matrix metalloproteinase-9 in human follicular fluid is associated with in vitro fertilization pregnancy. BJOG. 2005;112(7):946–51.

    Article  PubMed  CAS  Google Scholar 

  16. Liu B, Cai LY, Lv HM, Xia L, Zhang YJ, Zhang HX, Guan YM. Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1. Gynecol Endocrinol. 2008;24(5):285–8.

    Article  PubMed  Google Scholar 

  17. Naruse K, Lash GE, Innes BA, Otun HA, Searle RF, Robson SC, Bulmer JN. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy. Hum Reprod. 2009;24(3):553–61.

    Article  PubMed  CAS  Google Scholar 

  18. Ny T, Wahlberg P, Brändström IJ. Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol Cell Endocrinol. 2002;187(1–2):29–38.

    Article  PubMed  CAS  Google Scholar 

  19. Ogiwara K, Takano N, Shinohara M, Murakami M, Takahashi T. Gelatinase A and membrane-type matrix metalloproteinases 1 and 2 are responsible for follicle rupture during ovulation in the medaka. Proc Natl Acad Sci U S A. 2005;102(24):8442–7.

    Article  PubMed  CAS  Google Scholar 

  20. O’Sullivan MJB, Stamoui A, Thomas ES, Richardson MC. Gonadotropin regulation of production of tissue inhibitor of metalliproteinases and by luteinized human granulated cells a potential mechanism for luteal rescue. Mol Hum Reprod. 1997;3:405–14.

    Article  PubMed  Google Scholar 

  21. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and regulation of tissue remodeling. Nat Rev Mol Cell Biol. 2007;8(3):221–33.

    Article  PubMed  CAS  Google Scholar 

  22. Riley SC, Gibson AH, Leask R, Mauchline DJW, Pedersen HG, Watson ED. Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries. Reproduction. 2001;121:553–60.

    Article  PubMed  CAS  Google Scholar 

  23. Russell L, Salamunsen LA, Findlay LR. Immunization against the N-terminal peptide of the inhibin alphaY3-subunit (Alpha N) disrupts tissue remodeling and the increase in matrix metalloproteinase-2 during ovulation. Endocrinology. 1995;136:3657–64.

    Article  PubMed  CAS  Google Scholar 

  24. Seval Y, Cakmak H, Kayisli UA, Arici A. Estrogen-mediated regulation of p38 mitogen-activated protein kinase in human endometrium. J Clin Endocrinol Metab. 2006;91(6):2349–57.

    Article  PubMed  CAS  Google Scholar 

  25. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Ann Rev Cell Dev Biol. 2001;17:463–516.

    Article  CAS  Google Scholar 

  26. Tsafriri A, Reich R. Molecular aspects of mammalian ovulation. Exp Clin Endocrinol Diabetes. 1999;107(1):1–11.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Research Program P25/LF1/2 and SVV-2012-264512 Projects of Charles University in Prague.

Author information

Authors and Affiliations

  1. General University Hospital and 1st Faculty of Medicine of Charles University in Prague, U nemocnice 2, 128 00, Prague 2, Czech Republic

    Petra Horka, Karin Malickova, Radka Jarosova, Ivana Janatkova, Tomas Zima & Marta Kalousova

  2. Institute of Medical Biochemistry and Laboratory Diagnostics, Karlovo namesti 32, 121 11, Prague 2, Czech Republic

    Petra Horka, Karin Malickova, Ivana Janatkova, Tomas Zima & Marta Kalousova

  3. Department of Gynecology and Obstetrics, Prague 2, Czech Republic

    Radka Jarosova

Authors
  1. Petra Horka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karin Malickova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Radka Jarosova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ivana Janatkova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomas Zima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marta Kalousova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karin Malickova.

Additional information

Capsule

We demonstrate that matrix metalloproteinase-9 (MMP-9) serum as well as follicular concentrations are related to a successful IVF resulting in pregnancy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horka, P., Malickova, K., Jarosova, R. et al. Matrix metalloproteinases in serum and the follicular fluid of women treated by in vitro fertilization. J Assist Reprod Genet 29, 1207–1212 (2012). https://doi.org/10.1007/s10815-012-9853-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-012-9853-4

Keywords

Search

Navigation